SAN FRANCISCO, April 03, 2018 -- Hagens Berman Sobol Shapiro LLP alerts investors in Henry Schein, Inc. (NASDAQ:HSIC) to the May 7, 2018 Lead Plaintiff deadline in the securities class action pending in the United States District Court for the Eastern District of New York. If you purchased or otherwise acquired Henry Schein securities between March 7, 2013 and February 12, 2018 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/HSIC
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing
On February 12, 2018, the United States Federal Trade Commission (“FTC”) announced it sued Henry Schein and two other dental supply companies.
The FTC charges the Company: (a) illegally restrained price competition for dental products in the United States; (b) distorted prices and undermined the ability of independent dentists to obtain lower prices and discounts for dental products; (c) deprived independent dentists of the benefits of vigorous price and service competition among full-service, national dental distributors; (d) unreasonably reduced output of dental products to dental buying groups; and (e) eliminated or reduced the competitive bidding process for sales to these buying groups.
This news drove the price of Henry Schein shares down $4.79, or about 6.6%, to close at $67.39 on February 13, 2018.
“Henry Schein investors have suffered enormous losses,” said Hagens Berman partner Reed Kathrein. “We’re focused on Defendants’ statements to investors about the Company’s revenues and purported industry competition.”
Whistleblowers: Persons with non-public information regarding Henry Schein should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 70+ attorneys in 11 offices across the country. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact:
Reed Kathrein, 510-725-3000


Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
Capital One Says AML Review Led to Closure of Trump Organization Accounts
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations 



